Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Numinus Wellness's share price for the quarter that ended in Feb. 2024 was €0.0723. Numinus Wellness's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 320.55 Mil. Therefore, Numinus Wellness's market cap for the quarter that ended in Feb. 2024 was €23.18 Mil.
Numinus Wellness's quarterly market cap
declined
from Aug. 2023 (€34.32 Mil) to Nov. 2023 (€16.91 Mil) but then
increased
from Nov. 2023 (€16.91 Mil) to Feb. 2024 (€23.18 Mil).
Numinus Wellness's annual market cap
declined
from Aug. 2021 (€113.93 Mil) to Aug. 2022 (€69.93 Mil) and
declined
from Aug. 2022 (€69.93 Mil) to Aug. 2023 (€34.32 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Numinus Wellness's Enterprise Value for Today is €15.04 Mil.
Numinus Wellness Market Cap Historical Data
The historical data trend for Numinus Wellness's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Numinus Wellness's Market Cap
For the Medical Care Facilities subindustry, Numinus Wellness's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numinus Wellness's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's Market Cap distribution charts can be found below:
* The bar in red indicates where Numinus Wellness's Market Cap falls into.
Numinus Wellness Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Numinus Wellness's Market Cap for the fiscal year that ended in Aug. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Numinus Wellness (FRA:LR23) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Numinus Wellness Market Cap Related Terms
Thank you for viewing the detailed overview of Numinus Wellness's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:LR23 has been successfully added to your 